Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on June 10, 2008
JNCI Journal of the National Cancer Institute 2008 100(12):829; doi:10.1093/jnci/djn220
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/12/829-a    most recent
djn220v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

MEMO TO THE MEDIA

Raloxifene Reduces Risk of Invasive Estrogen-Receptor Positive Breast Cancer

The first 10% of the full text of this article appears below.

Women who took raloxifene were less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who did not, according to data from a randomized controlled trial published online June 10 in the Journal of the National Cancer Institute. The drug did not reduce the risk of non-invasive cancer or invasive ER-negative cancers.

A previous . . . [Full Text of this Article]

Contact:

Citation:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk
Deborah Grady, Jane A. Cauley, Mary Jane Geiger, Marcel Kornitzer, Lori Mosca, Peter Collins, Nanette K. Wenger, Jingli Song, John Mershon, and Elizabeth Barrett-Connor For the Raloxifene Use for The Heart Trial Investigators
J Natl Cancer Inst 2008 100: 854-861. [Abstract] [Full Text] [PDF]

The Rise of Raloxifene and the Fall of Invasive Breast Cancer
V. Craig Jordan
J Natl Cancer Inst 2008 100: 831-833. [Extract] [Full Text] [PDF]

Raloxifene Reduces Risk of Invasive Estrogen-Receptor Positive Breast Cancer
J Natl Cancer Inst 2008 100: 829. [Extract] [Full Text] [PDF]